Aptah Bio
PrivateLast Round
Seed
Dec 24, 2024
Total Funding Raised
$18M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aptah Bio is a biotechnology company that develops first-in-class RNA therapeutics targeting U1 snRNP dysfunction to slow tumor evolution, reduce cancer heterogeneity, and overcome adaptive resistance in glioblastoma and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptah Bio Comparables
Compare Aptah Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ceptur Therapeutics | 84% | |
| Skyhawk Therapeutics | 72% | |
| Inverna Therapeutics | 72% |
Aptah Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 24, 2024 | ||||
| Series A | Aug 14, 2023 | ||||
| Accelerator | Aug 26, 2021 |
Key People
Founding team and executive leadership
Aptah Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taihill Venture | Seed |
| 5Y Capital | Seed |
| K2VC | Seed |
| UpHonest Capital | Seed |
| Financiadora de Estudos e Projetos | Series A |
| Mission BioCapital | Series A |
| Vesper | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 116% MoM, reaching 2K.
- Jul 24, 2026
Monthly visitors increased 253% MoM.
Aptah Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aptah Bio's valuation, stock price, and market status.
Is Aptah Bio a public or private company?
Aptah Bio is a private company.
What is the current stock price of Aptah Bio?
Aptah Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Aptah Bio worth (valuation)?
Valuation information for Aptah Bio is not publicly available.
Can I buy Aptah Bio stock?
Aptah Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aptah Bio's last funding round?
Aptah Bio's most recent funding round was Seed on December 24, 2024.
Who are the main investors in Aptah Bio?
Key investors in Aptah Bio include Taihill Venture, 5Y Capital, K2VC, MBC BioLabs, UpHonest Capital.
Will Aptah Bio IPO soon?
No public IPO plans have been announced for Aptah Bio.
How can I track Aptah Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aptah Bio's secondary market activity and sign up for updates.